Pyoderma Gangrenosum Treatment Market is Driven by Biologic Innovation
The Pyoderma gangrenosum treatment market comprises advanced therapies and biologics aimed at managing the rare inflammatory skin disorder characterized by painful ulcers. Treatment options include systemic immunosuppressants such as corticosteroids, cyclosporine, TNF inhibitors, and emerging monoclonal antibodies targeting interleukin-23 and interleukin-17 pathways. The market benefits from...
0 Commentaires 0 Parts 142 Vue 0 Aperçu